within Pharmacolibrary.Drugs.ATC.R;

model R06AX32
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.3333333333333333,
    adminDuration  = 600,
    adminMass      = 0.05,
    adminCount     = 1,
    Vd             = 0.015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Sequifenadine is a non-sedating antihistamine drug, primarily developed and used in Russia for the treatment of allergic conditions like allergic rhinitis and urticaria. It acts as a selective H1 receptor antagonist. The drug is not widely approved or in use outside of some Eastern European countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult subjects based on comparable oral second-generation antihistamines, as no direct human pharmacokinetic studies are published or referenced in scientific literature.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R06AX32;
